Related Experiment Video
Updated: Oct 14, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Different hypertension thresholds and cognitive decline: a pooled analysis of three ageing cohorts
Yanjun Ma1,2,3, Rong Hua1,2, Zhenchun Yang4
1Peking University Clinical Research Institute, Peking University First Hospital, Beijing, China.
Insights
Individuals with borderline blood pressure (BP) between 130/80 and 140/90 mmHg did not show increased cognitive decline. This suggests that antihypertension therapy may not be necessary for this group, considering cognitive health.
Area of Science:
- Gerontology
- Cardiology
- Neurology
Background:
- Conflicting definitions of hypertension exist: 2017 ACC/AHA guidelines define it as ≥130/80 mmHg, while 2018 ESC/ESH guidelines use ≥140/90 mmHg.
- This discrepancy impacts clinical decisions regarding blood pressure management.
Purpose of the Study:
- To compare cognitive decline trajectories in adults based on differing blood pressure (BP) thresholds.
- To investigate the impact of borderline BP (130/80-140/90 mmHg) on cognitive function compared to normal BP (<130/80 mmHg).
Main Methods:
- Pooled analysis of three large, nationally representative cohorts: Health and Retirement Study (HRS), English Longitudinal Study of Ageing (ELSA), and China Health Retirement Longitudinal Study (CHARLS).
- Participants were categorized into Normal (BP <130/80 mmHg), Borderline (BP <140/90 mmHg but not Normal), and High BP groups.
- Global cognitive function was assessed using memory, executive function, and orientation tests, with a global cognitive Z-score calculated.
Main Results:
- No significant difference in the rate of global cognitive decline was observed between the Normal and Borderline BP groups for both men and women.
- Participants in the High BP group exhibited a significantly faster rate of cognitive decline compared to the Borderline BP group.
- The study included 17,590 participants with median follow-up periods ranging from 7 to 16 years.
Conclusions:
- Borderline blood pressure levels (130/80-140/90 mmHg) are not associated with a significantly faster rate of cognitive decline compared to normal levels.
- Initiating antihypertension therapy for individuals with borderline BP may not be necessary solely based on concerns about cognitive decline.
Background:
The 2017 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for high blood pressure (BP) in adults came up with a new definition of hypertension with a threshold BP level of 130/80 mmHg. But the 2018 European Society of Cardiology (ESC)/European Society of Hypertension (ESH) guidelines adhered to a conventional hypertension definition as BP ≥ 140/90 mmHg. We aimed to compare the trajectories of cognitive decline between participants with BP < 130/80 mmHg in all BP measurement waves and others with all BP < 140/90 mmHg.
Methods:
This pooled analysis involved middle-aged and older participants from three nationally representative ageing cohorts, including the Health and Retirement Study (HRS), the English Longitudinal Study of Ageing (ELSA), and the China Health Retirement Longitudinal Study (CHARLS). Participants were divided into the Normal (BP < 130/80 mmHg on all occasions throughout the study), the Borderline (BP < 140/90 mmHg on all occasions throughout the study but not in the Normal group), and the High (the rest of participants) BP groups. Global cognitive Z score was calculated from tests on memory, executive function, and orientation.
Results:
A total of 17,590 participants (HRS 6964, median follow-ups 12 years; ELSA 5334, median follow-ups 16 years; CHARLS 5292, median follow-ups 7 years) were included. No significant difference in global cognitive decline rate was detected between the Normal and the borderline groups (men, pooled β = - 0.006 standard deviation [SD]/year; 95% confidence interval [CI], - 0.020 to 0.008; P = 0.377; women, pooled β = 0.006 SD/year; 95% CI - 0.005 to 0.018; P = 0.269). Participants in the High group had a significantly faster cognitive decline (men, pooled β = - 0.011 SD/year; 95% CI - 0.020 to - 0.002; P = 0.013; women, pooled β = - 0.017 SD/year; 95% CI - 0.026 to - 0.008; P < 0.001) than that in the Borderline group.
Conclusions:
Individuals in the Borderline group did not experience significantly faster cognitive decline compared with those in the Normal group. It might not be necessary for individuals with borderline BP (between 130/80 and 140/90 mmHg) to initiate antihypertension therapy in consideration of cognitive decline.
More Related Videos
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Hypertension III: Clinical Manifestations and Diagnostic Studies
Drug Dosing: Geriatric Patients
Hypertension I: Introduction
Cognitive Development During Adulthood
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...

